High-level pan-azole-resistant aspergillosis

Journal of Clinical Microbiology

Volumn 53, Issue 7, 2015, Pages 2343-2345

  Van Ingen, Jakko ^a   Van Der Lee, Henrich A L ^a   Rijs, Antonius J M M ^a   Snelders, Eveline ^a   Melchers, Willem J G ^a   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; CYTOCHROME P-450 CYP51A, ASPERGILLUS; CYTOCHROME P450; FUNGAL PROTEIN; PYRROLE DERIVATIVE;

ADULT; AGED; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHIECTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DETERIORATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FUNGUS ISOLATION; GRANULOMATOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LUNG ASPERGILLOSIS; LUNG HEMORRHAGE; LUNG SARCOIDOSIS; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; PHENOTYPE; PLEURA EMPYEMA; PNEUMOTHORAX; PRIORITY JOURNAL; SHOULDER ARTHRITIS; STERNOCLAVICULAR JOINT; STEROID THERAPY; VISUAL DISORDER; YOUNG ADULT; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION;

ASPERGILLUS FUMIGATUS;

ADULT; AGED; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; FUNGAL PROTEINS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; PULMONARY ASPERGILLOSIS; YOUNG ADULT;

EID: 84932607353     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00502-15     Document Type: Article

References (16)

1. Vermeulen E, Lagrou K, Verweij PE. 2013. Azole resistance in Aspergillus fumigatus: a growing public health concern. Curr Opin Infect Dis 26:493-500. http://dx.doi.org/10.1097/QCO.0000000000000005.
2. 46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands. J Antimicrob Chemother 70:178-181. http://dx.doi.org/10.1093/jac/dku364.
3. Seyedmousavi S, Mouton JW, Melchers WJ, Brüggemann RJ, Verweij PE. 2014. The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside. Drug Resist Updat 17:37-50. http://dx.doi.org/10.1016/j.drup.2014.06.001.
4. Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW. 2013. Breakpoints for antifungal agents: an update from EUCAST focusing on echinocandins against Candida spp. and triazoles against Aspergillus spp. Drug Resist Updat 16:81-95. http://dx.doi.org/10.1016/j.drup.2014.01.001.
5. van der Linden JW, Camps SM, Kampinga GA, Arends JP, Debets-Ossenkopp YJ, Haas PJ, Rijnders BJ, Kuijper EJ, van Tiel FH, Varga J, Karawajczyk A, Zoll J, Melchers WJ, Verweij PE. 2013. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 57:513-520. http://dx.doi.org/10.1093/cid/cit320.
6. Gregson L, Goodwin J, Johnson A, McEntee L, Moore CB, Richardson M, Hope WW, Howard SJ. 2013. In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole. Antimicrob Agents Chemother 57:5778-5780. http://dx.doi.org/10.1128/AAC.01141-13.
7. Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ. 2009. Azole resistance in Aspergillus fumigatus: a side effect of environmental fungicide use? Lancet Infect Dis 9:789-795. http://dx.doi.org/10.1016/S1473-3099(09)70265-8.
8. Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ. 2012. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother 56:10-16. http://dx.doi.org/10.1128/AAC.05088-11.
9. Albarrag AM, Anderson MJ, Howard SJ, Robson GD, Warn PA, Sanglard D, Denning DW. 2011. Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of I, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob Agents Chemother 55:5113-5121. http://dx.doi.org/10.1128/AAC.00517-11.
10. Fraczek MG, Bromley M, Buied A, Moore CB, Rajendran R, Rautemaa R, Ramage G, Denning DW, Bowyer P. 2013. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. J Antimicrob Chemother 68:1486-1496. http://dx.doi.org/10.1093/jac/dkt075.
11. Buied A, Moore CB, Denning DW, Bowyer P. 2013. High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates. J Antimicrob Chemother 68:512-514. http://dx.doi.org/10.1093/jac/dks451.
12. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS, Denning DW. 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 15:1068-1076. http://dx.doi.org/10.3201/eid1507.090043.
13. Lepak AJ, Marchillo K, VanHecker J, Andes DR. 2013. Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates. Antimicrob Agents Chemother 57:5438-5447. http://dx.doi.org/10.1128/AAC.00833-13.
14. Seyedmousavi S, Melchers WJ, Mouton JW, Verweij PE. 2013. Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis. Antimicrob Agents Chemother 57:1866-1871. http://dx.doi.org/10.1128/AAC.02226-12.
15. Denning DW, Park S, Lass-Florl C, Fraczek MG, Kirwan M, Gore R, Smith J, Bueid A, Moore CB, Bowyer P, Perlin DS. 2011. Highfrequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 52: 1123-1129. http://dx.doi.org/10.1093/cid/cir179.
16. Spiess B, Seifarth W, Merker N, Howard SJ, Reinwald M, Dietz A, Hofmann WK, Buchheidt D. 2012. Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients. Antimicrob Agents Chemother 56:3905-3910. http://dx.doi.org/10.1128/AAC.05902-11.